Emine Altin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Emine Altin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ayşe Betül Acar
Department of Pain Clinic, Etlik City Hospital Ankara, Ankara, Türkiye
1 shared publication - Belgin Kocer
Gazi University Faculty of Medicine, Department of Neurology, Ankara, Turkey
1 shared publication - Beyza Çiftci
Gazi Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Mevlana St 89, TR-06560 Ankara, Turkiye
1 shared publication - Ece Yanık
Department of Neurology and Pain Medicine, Neuropsychiatry Center, Gazi University, Ankara, Türkiye
1 shared publication - Hamid Habibi
Department of Infectious Diseases and Clinical Microbiology, Gazi University Medical School
1 shared publication - Murat Dizbay
Gazi Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Ankara, Turkiye
1 shared publication
Latest Publications
- 20 March 2025
- Published by Taylor & Francis in Neurological Research
- Vol. 47 (5) , 402-405
Is artificial intelligence successful in the Turkish neurology board exam?
OpenAI declared that GPT-4 performed better in academic and certain specialty areas. Medical licensing exams assess the clinical competence of doctors. We aimed to investigate for the first time howChatGPT will perform in the Turkish Neurology Proficiency Exam. TheGPT-4 version of ChatGPT was used in the study due to the presence ofimage-based questions. The multiple-choice sections of the TurkishNeurology Proficiency Exams conducted by the Turkish NeurologyAssociation (TND) in 2021, 2022 and 2023 were applied to ChatGPT-4.Questions and multiple-choice answers were used in their originalTurkish forms in the official national examination standards. The success rate in all three exams ranges from 79% to 82%. There were common and different mistakes in the two trials. When the incorrect answers were re-evaluated, the correct answers were obtained. This is the first study to investigate the performance of ChatGPT on the real Neurology Proficiency Examination. The success rate was shown to be above GPT-3.5. Furthermore, this study showed that translating questions from the original language into English did not affect the performance of GPT-4 in medical licensing exams, unlike GPT-3.5. It is therefore very important that the information obtained is accurate and verifiable. ChatGPT-4's ability to find the correct answer with feedback on questions that it initially answered incorrectly may be due to the model's ability to generate flexible and adaptive answers.These models should be used carefully and consciously, knowing that they will not always give the correct answer.
- 20 March 2025
- Published by Taylor & Francis in Neurological Research
- Vol. 47 (5) , 402-405
Is artificial intelligence successful in the Turkish neurology board exam?
OpenAI declared that GPT-4 performed better in academic and certain specialty areas. Medical licensing exams assess the clinical competence of doctors. We aimed to investigate for the first time howChatGPT will perform in the Turkish Neurology Proficiency Exam. TheGPT-4 version of ChatGPT was used in the study due to the presence ofimage-based questions. The multiple-choice sections of the TurkishNeurology Proficiency Exams conducted by the Turkish NeurologyAssociation (TND) in 2021, 2022 and 2023 were applied to ChatGPT-4.Questions and multiple-choice answers were used in their originalTurkish forms in the official national examination standards. The success rate in all three exams ranges from 79% to 82%. There were common and different mistakes in the two trials. When the incorrect answers were re-evaluated, the correct answers were obtained. This is the first study to investigate the performance of ChatGPT on the real Neurology Proficiency Examination. The success rate was shown to be above GPT-3.5. Furthermore, this study showed that translating questions from the original language into English did not affect the performance of GPT-4 in medical licensing exams, unlike GPT-3.5. It is therefore very important that the information obtained is accurate and verifiable. ChatGPT-4's ability to find the correct answer with feedback on questions that it initially answered incorrectly may be due to the model's ability to generate flexible and adaptive answers.These models should be used carefully and consciously, knowing that they will not always give the correct answer.
- 16 February 2023
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 29 (1) , 111-115
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report
Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease of the central nervous system caused by reactivation of the polyomavirus JC (JCV). Human immunodeficiency virus (HIV) infection is one of the leading causes of PML which has high morbidity and mortality due to the lack of a proven standard treatment. We found clinical and radiological improvement with the combination of high-dose methylprednisolone, mirtazapine, mefloquine, and IVIG in our patient who presented with neurological symptoms and had diagnosed concurrent acquired immunodeficiency syndrome (AIDS) and PML. To our knowledge, our case is the first HIV-associated PML which responded to this combination therapy.
- 16 February 2023
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 29 (1) , 111-115
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report
Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease of the central nervous system caused by reactivation of the polyomavirus JC (JCV). Human immunodeficiency virus (HIV) infection is one of the leading causes of PML which has high morbidity and mortality due to the lack of a proven standard treatment. We found clinical and radiological improvement with the combination of high-dose methylprednisolone, mirtazapine, mefloquine, and IVIG in our patient who presented with neurological symptoms and had diagnosed concurrent acquired immunodeficiency syndrome (AIDS) and PML. To our knowledge, our case is the first HIV-associated PML which responded to this combination therapy.